Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon versus sevoflurane anesthesia in off-pump coronary artery bypass graft surgery
2012-002316-12Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2012
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in coronary arteriosclerosis (2 arms), sponsored by UZ Leuven. Primary endpoint: Feasibility and safety of xenon application compared to sevoflurane. Started Jul 2012; status: completed.
02
Drugs
xenon
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2012-002316-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002316-12.